BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
BillionToOne (NASDAQ: BLLN) announced management will participate in the 44th Annual J.P.
Rhea-AI Summary
BillionToOne (NASDAQ: BLLN) announced management will participate in the 44th Annual J.P. Morgan Healthcare Conference.
The presentation is scheduled for Monday, January 12, 2026, from 9:45 AM to 10:25 AM PT. A live and archived webcast will be available on BillionToOne's Events & Presentations investor page at https://investors.billiontoone.com/news-events/events-presentations.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BLLN
On Dec 23, the day this news came out, BLLN closed 9.57% below the previous close.
Data tracked by StockTitan Argus for the Dec 23 session.
Key Figures
- Conference edition
- 44th
- 44th Annual J.P. Morgan Healthcare Conference
- Presentation start time
- 9:45am Pacific Time
- Conference presentation window
- Presentation end time
- 10:25am Pacific Time
- Conference presentation window
- Presentation date
- January 12, 2026
- J.P. Morgan Healthcare Conference slot
Historical Context
-
Appointment of experienced CFO Anthony Pagano as Audit Committee Chair.
-
Strong Q3 2025 revenue growth, margin expansion and positive operating income.
-
Announcement of Q3 2025 results release date and conference call details.
-
Closing of upsized IPO and full exercise of underwriters’ option for extra shares.
-
Law firm announcement detailing BillionToOne’s upsized IPO and bookrunners.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
molecular diagnostics medical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference.
Management will present from 9:45am to 10:25am Pacific Time on Monday, January 12th, 2026.
A live and archived webcast will be available on the “Events & Presentations” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/news-events/events-presentations.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.
Investor Contact
ir@billiontoone.com
Media Contact
billiontoone@moxiegrouppr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.